| Literature DB >> 16870427 |
Namal C Warshakoon1, Justin Sheville, Ritu Tiku Bhatt, Wei Ji, Jose L Mendez-Andino, Kenneth M Meyers, Nick Kim, John A Wos, Chrissy Mitchell, Jennifer L Paris, Beth B Pinney, Ofer Reizes, X Eric Hu.
Abstract
A novel series of substituted quinoline analogs were designed and synthesized as potent and selective melanin concentrating hormone (MCH) antagonists. These analogs show potent (nM) activity (12a-k) with a moderate selectivity. Conversely, the conformationally constrained thienopyrimidinone analogs (18a-g) showed improved activity in MCH-1R and selectivity over 5HT2C.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16870427 DOI: 10.1016/j.bmcl.2006.07.006
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823